Harpoon Therapeutics, Inc.
Pagina dedicata companiei Harpoon Therapeutics, Inc. listata cu simbolurile US.HARP, US.HARPc
Descriere companieModificare
Harpoon Therapeutics,(https://www.harpoontx.com/) Inc. is a clinical-stage immunotherapy company. The Company is engaged in the development of a novel class of T cell engagers that harness the power of the body’s immune system to treat patients suffering from cancer and other diseases. The Company is engaged in developing pipeline of novel T cell engagers using TriTACs, focused on the treatment of solid tumors and hematologic malignancies. It has also nominated its clinical candidate using ProTriTAC platform, a prodrug version of TriTAC platform, designed to expand the target space for T cell engagers and bring the benefits of TriTACs to the patients. The Company’s four TriTAC product candidates include HPN424, HPN536, HPN217 and HPN328. The Company ProTriTAC product candidate include HPN601.
Grafic actiuni companieModificare